Risk Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia
Study phase: III
Primary disease category: Leukemia & Lymphoma
Sponsor: Children's Oncology Group
Protocol number: AALL1331
Projected enrollment dates: January 2015 to June 2020
Official study title: Risk Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/02101853